Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

The EXCEL Authors’ Answer to the BBC Investigation

Do to an investigation carried out by the BBC that led to the withdrawal of EACTS support from the latest coronary revascularization guidelines, the authors of the EXCEL study (indicated by this research) provided the following answers.

Escándalo con los resultados del EXCEL que hicieron “caer” las últimas guías

-Defining Peri-Procedural Infarction:

All researchers involved (including surgeons) agreed that the universal definition of infarction was not right for this study. This was because the universal definition criteria are different for PCI and surgery. Furthermore, their association to prognosis has not been shown. The EXCEL protocol criteria are uniform, and they have certainly been linked to prognosis.

The BBC investigation claims the research criteria were modified, which is absolutely incorrect. 

-Peri-procedural infarction rates were deliberately omitted:

Using the universal definition of infarction was one of the 35 exploratory secondary end points. The universal definition is based on troponins and, unfortunately, this data was missing in most patients. Therefore, there were no infarction reports using the universal definition criteria. Nevertheless, researchers were planning to report infarction rate according to multiple definitions, including of course the universal definition. 


Read also: Latest Guidelines “Dropped” After Scandal Over EXCEL Results.


-All cause mortality rate was not emphasized enough: 

All-cause mortality was a secondary end point and the sample had no statistical power to show anything. The modest difference in mortality between the groups was not adjusted, which made it impossible to draw any conclusions. Besides, mortality was caused mainly by sepsis and cancer several years after randomization, according to an events committee. A meta analyzis with 4394 patients from 4 randomized studies on PCI with DES vs. CABG (including the EXCEL) did no show differences in mortality at 5 years between the revascularization strategies.

Not even SYNTAX data at 10 years showed differences in mortality.

Unfortunately, the difference between all-cause and cardiovascular mortality was not mentioned in the BBC investigation. 

-The safety committee issued alerts that were not taken into account:

The independent safety monitoring committee often followed up on raw data and suggested staying on track as planned, with no amends. 

-The ESC/EAPCI/EACTS guidelines are not safe:

Guidelines are written based on a stack of evidence from multiple studies carried out by independent experts. The current guidelines (based partly on the EXCEL) suggest PCI can be considered a viable alternative for select patients with left main disease. 

2020-01-03-response-final

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...